share_log

HC Wainwright & Co. Initiates Coverage On OKYO Pharma With Buy Rating, Announces Price Target of $4

HC Wainwright & Co. Initiates Coverage On OKYO Pharma With Buy Rating, Announces Price Target of $4

HC Wainwright & Co.以買入評級啓動對OKYO Pharma的報道，宣佈目標股價爲4美元
Benzinga ·  2023/11/02 19:07

HC Wainwright & Co. analyst Yi Chen initiates coverage on OKYO Pharma (NASDAQ:OKYO) with a Buy rating and announces Price Target of $4.

HC Wainwright & Co. 分析師陳毅以買入評級開始對OKYO Pharma（納斯達克股票代碼：OKYO）進行報道，並宣佈目標股價爲4美元。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論